Fecal microbiota transplantation mitigates respiratory infection in rats exposed to hypobaric hypoxia by modulating the NLRP3 inflammasome and mucosal immunity
PLOS One · 28.04.2026 · 21 (4) · e0347857
DOI: 10.1371/journal.pone.0347857 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 28.04.2026. Verfasst von Huan Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, General Hospital of Western Theater Command, Chengdu, Sichuan, P. R. China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Inflammasomes, Hypoxia, Fecal Microbiota Transplantation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chengdu Medical College.
Abstract (Originalsprache)
Objective
To investigate the role of the gut-lung axis in respiratory infection under hypobaric hypoxia and the therapeutic potential of fecal microbiota transplantation (FMT).
Methods
Rats were exposed to hypobaric hypoxia (simulated 5000 m) for 14 days. Gut microbiota and serum short-chain fatty acids (SCFAs) were analyzed via 16S rRNA sequencing and GC-MS. Rats were then infected with Streptococcus pneumoniae and treated with FMT. Lung inflammation, NLRP3 inflammasome activity, cytokines, bacterial load, and secretory IgA (sIgA) were assessed.
Results
Hypobaric hypoxia triggered gut dysbiosis, marked by reduced abundance of Firmicutes D and Lactobacillus, elevated Bacteroidota , and decreased SCFA levels..FMT restored microbiota composition, increased acetic and butyric acid levels, and attenuated lung inflammation. FMT also enhanced NLRP3 inflammasome activation (NLRP3, ASC, Caspase-1), elevated IL-1β, IL-6, and TNF-α in BALF, reduced bacterial colonies, and increased airway sIgA in infected rats.
Conclusions
FMT alleviates hypobaric hypoxia-aggravated respiratory infection by restoring gut microbiota, modulating SCFAs, and enhancing NLRP3-mediated mucosal immunity, highlighting the gut-lung axis as a therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, General Hospital of Western Theater Command, Chengdu, Sichuan, P. R. China.
- Basic Medical Laboratory, General Hospital of the Western Theater of Command, Chengdu, Sichuan, P. R. China.
- Department of General Surgery, General Hospital of the Western Theater of Command, Chengdu, Sichuan, P. R. China.
- Department of Hyperbaric Oxygen, General Hospital of the Western Theater of Command, Chengdu, Sichuan, P. R. China.
ORCID-Profile: Jing Zhou
Förderung
- Chengdu Medical College
Zitieren
APA
Wang, H., Wu, Z., Zhang, Y., Tang, L., Shi, G., Ma, L., Huang, Z., & Zhou, J. (2026). Fecal microbiota transplantation mitigates respiratory infection in rats exposed to hypobaric hypoxia by modulating the NLRP3 inflammasome and mucosal immunity. PLOS One, 21(4), e0347857. https://doi.org/10.1371/journal.pone.0347857
Vancouver
Wang H, Wu Z, Zhang Y, Tang L, Shi G, Ma L, et al. Fecal microbiota transplantation mitigates respiratory infection in rats exposed to hypobaric hypoxia by modulating the NLRP3 inflammasome and mucosal immunity. PLOS One. 2026;21(4):e0347857. doi:10.1371/journal.pone.0347857
BibTeX
@article{Wang2026,
author = {Wang, Huan and Wu, Zhenyan and Zhang, Yaolei and Tang, Lijun and Shi, Guangqing and Ma, Lijie and Huang, Zhu and Zhou, Jing},
title = {Fecal microbiota transplantation mitigates respiratory infection in rats exposed to hypobaric hypoxia by modulating the NLRP3 inflammasome and mucosal immunity},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {4},
pages = {e0347857},
doi = {10.1371/journal.pone.0347857}
}
EUVIMED